These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
280 related articles for article (PubMed ID: 37215879)
1. Identification of anoikis-related subtypes and development of risk stratification system in skin cutaneous melanoma. Tian J; Cao ZJ; Zhang Y; Zhou JK; Yang L Heliyon; 2023 May; 9(5):e16153. PubMed ID: 37215879 [TBL] [Abstract][Full Text] [Related]
2. The Landscape of the Tumor Microenvironment in Skin Cutaneous Melanoma Reveals a Prognostic and Immunotherapeutically Relevant Gene Signature. Zhou S; Sun Y; Chen T; Wang J; He J; Lyu J; Shen Y; Chen X; Yang R Front Cell Dev Biol; 2021; 9():739594. PubMed ID: 34660598 [TBL] [Abstract][Full Text] [Related]
3. A promising anoikis-related prognostic signature predicts prognosis of skin cutaneous melanoma. Yue Z; Wang D; Li X J Cancer Res Clin Oncol; 2023 Dec; 149(20):17757-17770. PubMed ID: 37930439 [TBL] [Abstract][Full Text] [Related]
4. Development of a biomarker signature associated with anoikis to predict prognosis and immunotherapy response in melanoma. Wu Z; Zhang R; Bao J; Yin M; Wang X Arch Dermatol Res; 2024 May; 316(6):219. PubMed ID: 38787413 [TBL] [Abstract][Full Text] [Related]
5. Integrative lactylation and tumor microenvironment signature as prognostic and therapeutic biomarkers in skin cutaneous melanoma. Zhu Y; Song B; Yang Z; Peng Y; Cui Z; Chen L; Song B J Cancer Res Clin Oncol; 2023 Dec; 149(20):17897-17919. PubMed ID: 37955686 [TBL] [Abstract][Full Text] [Related]
6. Analysis on tumor immune microenvironment and construction of a prognosis model for immune-related skin cutaneous melanoma. Wu M; Wang Z; Zhang J Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 May; 48(5):671-681. PubMed ID: 37539569 [TBL] [Abstract][Full Text] [Related]
7. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer. Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X Front Immunol; 2022; 13():1056932. PubMed ID: 36479114 [TBL] [Abstract][Full Text] [Related]
8. Analysis of differential gene immune infiltration and clinical characteristics of skin cutaneous melanoma based on systems biology and drug repositioning methods to identify drug candidates for skin cutaneous melanoma. Long S; Xu J; Huang H Naunyn Schmiedebergs Arch Pharmacol; 2023 Oct; 396(10):2427-2447. PubMed ID: 37086280 [TBL] [Abstract][Full Text] [Related]
9. Identification of Novel Anoikis-Related Gene Signatures to Predict the Prognosis, Immune Microenvironment, and Drug Sensitivity of Breast Cancer Patients. Liu J; Wu H; Wang Q; Jin S; Hou S; Shen Z; Zhao L; Xu S; Pang D Cancer Control; 2024; 31():10732748241288118. PubMed ID: 39340434 [TBL] [Abstract][Full Text] [Related]
10. Development and validation of an immune gene set-based prognostic signature in cutaneous melanoma. Tian Q; Gao H; Zhao W; Zhou Y; Yang J Future Oncol; 2021 Nov; 17(31):4115-4129. PubMed ID: 34291650 [TBL] [Abstract][Full Text] [Related]
11. A novel anoikis-related gene prognostic signature and its correlation with the immune microenvironment in colorectal cancer. Xiao Y; Zhou H; Chen Y; Liu L; Wu Q; Li H; Lin P; Li J; Wu J; Tang L Front Genet; 2023; 14():1186862. PubMed ID: 37323657 [No Abstract] [Full Text] [Related]
12. Anoikis-related subtype and prognosis analyses based on bioinformatics, and an expression verification of ANGPTL4 based on experiments of lung adenocarcinoma. Shen X; Xie J; Liu S; Cai Y; Yuan S; Uehara Y; Zhu D; Zheng M J Thorac Dis; 2024 Aug; 16(8):5361-5378. PubMed ID: 39268091 [TBL] [Abstract][Full Text] [Related]
13. Correlation of CCL8 expression with immune cell infiltration of skin cutaneous melanoma: potential as a prognostic indicator and therapeutic pathway. Yang P; Chen W; Xu H; Yang J; Jiang J; Jiang Y; Xu G Cancer Cell Int; 2021 Nov; 21(1):635. PubMed ID: 34844613 [TBL] [Abstract][Full Text] [Related]
14. Characterization of coagulation-related gene signature to predict prognosis and tumor immune microenvironment in skin cutaneous melanoma. Song B; Chi H; Peng G; Song Y; Cui Z; Zhu Y; Chen G; Wu J; Liu W; Dong C; Wang Y; Xu K; Yu Z; Song B Front Oncol; 2022; 12():975255. PubMed ID: 36059641 [TBL] [Abstract][Full Text] [Related]
15. Identification of m6A-related lncRNAs-based signature for predicting the prognosis of patients with skin cutaneous melanoma. Lin W; Tan ZY; Fang XC SLAS Technol; 2024 Feb; 29(1):100101. PubMed ID: 37541541 [TBL] [Abstract][Full Text] [Related]
16. Identification and validation of TME-related signatures to predict prognosis and response to anti-tumor therapies in skin cutaneous melanoma. Lian W; Zheng X Funct Integr Genomics; 2023 May; 23(2):153. PubMed ID: 37160578 [TBL] [Abstract][Full Text] [Related]
17. A new ferroptosis-related genetic mutation risk model predicts the prognosis of skin cutaneous melanoma. He J; Huang W; Li X; Wang J; Nie Y; Li G; Wang X; Cao H; Chen X; Wang X Front Genet; 2022; 13():988909. PubMed ID: 36685905 [No Abstract] [Full Text] [Related]
18. Identification of a novel tumour microenvironment-based prognostic biomarker in skin cutaneous melanoma. Yang RH; Liang B; Li JH; Pi XB; Yu K; Xiang SJ; Gu N; Chen XD; Zhou ST J Cell Mol Med; 2021 Dec; 25(23):10990-11001. PubMed ID: 34755462 [TBL] [Abstract][Full Text] [Related]
19. Identification of an anoikis-related gene signature and characterization of immune infiltration in skin cutaneous melanoma. Xu Z; Huang J; Shi W; Qi Y; Yuan F; Lin B Medicine (Baltimore); 2024 Apr; 103(17):e37900. PubMed ID: 38669429 [TBL] [Abstract][Full Text] [Related]
20. Genes associated with cellular senescence favor melanoma prognosis by stimulating immune responses in tumor microenvironment. Liang X; Lin X; Lin Z; Lin W; Peng Z; Wei S Comput Biol Med; 2023 May; 158():106850. PubMed ID: 37031510 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]